Salvatore Brugaletta Selected Research

Hyperemia

1/2023	Treatment of Slow-Flow After Primary Percutaneous Coronary Intervention With Flow-Mediated Hyperemia: The Randomized RAIN-FLOW Study.
1/2018	Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.
7/2017	Rationale and design of the Hunting for the off-target propertIes of Ticagrelor on Endothelial function and other Circulating biomarkers in Humans (HI-TECH) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvatore Brugaletta Research Topics

Disease

64	ST Elevation Myocardial Infarction 01/2024 - 11/2008
56	Thrombosis (Thrombus) 12/2023 - 01/2009
48	Myocardial Infarction 12/2023 - 08/2007
23	Acute Coronary Syndrome 03/2024 - 11/2003
20	Hemorrhage 09/2023 - 09/2010
19	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 06/2008
18	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 11/2008
11	Stroke (Strokes) 01/2023 - 10/2010
10	Death (Near-Death Experience) 12/2022 - 07/2011
7	Diabetes Mellitus 10/2022 - 07/2011
7	Pathologic Constriction (Stenosis) 01/2022 - 03/2012
6	Infarction (Infarctions) 12/2021 - 11/2008
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2023 - 03/2013
5	Hyperplasia 10/2022 - 02/2011
5	Atrial Fibrillation 10/2021 - 10/2013
5	Neointima 08/2018 - 12/2011
4	Non-ST Elevated Myocardial Infarction 01/2024 - 01/2020
4	Atherosclerosis 01/2018 - 10/2009
4	Unstable Angina 09/2009 - 05/2006
3	Heart Failure 02/2023 - 08/2009
3	Hyperemia 01/2023 - 07/2017
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 06/2008
3	Renal Insufficiency (Renal Failure) 07/2018 - 06/2008
2	Heart Arrest (Cardiac Arrest) 09/2023 - 03/2012
2	Cardiogenic Shock 09/2023 - 12/2022
2	Coronary Disease (Coronary Heart Disease) 01/2023 - 01/2021
2	Left Ventricular Dysfunction 01/2023 - 01/2016
2	Aneurysm (Aneurysms) 03/2020 - 03/2014
2	Ischemia 05/2018 - 07/2011
2	Out-of-Hospital Cardiac Arrest 04/2017 - 01/2017
2	Embolism (Embolus) 04/2014 - 10/2013
2	Rupture 01/2014 - 03/2012
2	AIDS-Related Complex (ARC) 10/2013 - 04/2012
2	Atherosclerotic Plaque (Atheroma) 03/2012 - 07/2011
2	Inflammation (Inflammations) 10/2009 - 05/2006
2	Ventricular Remodeling 11/2008 - 08/2007
1	Pulmonary Edema 09/2023
1	Hypothermia 09/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2021
1	MINOCA 01/2021
1	Aortic Valve Insufficiency (Aortic Regurgitation) 11/2019
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 04/2019

Drug/Important Bio-Agent (IBA)

33	Everolimus FDA Link 07/2023 - 12/2011
22	MetalsIBA 10/2023 - 12/2011
15	omega-Chloroacetophenone (Mace)IBA 10/2023 - 06/2009
10	PolymersIBA 03/2024 - 06/2014
7	Sirolimus (Rapamycin)FDA Link 03/2024 - 01/2019
7	TicagrelorIBA 01/2020 - 06/2015
6	bivalirudin (Angiomax)FDA Link 06/2019 - 03/2015
6	Clopidogrel (Plavix)FDA Link 01/2018 - 06/2009
5	Biomarkers (Surrogate Marker)IBA 02/2023 - 11/2003
5	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2015
5	C-Reactive ProteinIBA 08/2010 - 11/2003
4	Dihydrotachysterol (AT 10)IBA 10/2023 - 06/2009
4	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 07/2017
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 06/2009
4	MagnesiumIBA 08/2022 - 01/2019
4	LipidsIBA 12/2021 - 10/2009
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2021 - 01/2017
4	Heparin (Liquaemin)FDA LinkGeneric 06/2019 - 02/2015
4	TroponinIBA 01/2018 - 11/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 11/2008
3	Glycoproteins (Glycoprotein)IBA 01/2018 - 11/2014
3	CobaltIBA 11/2014 - 12/2011
3	ChromiumIBA 11/2014 - 12/2011
2	CalciumIBA 04/2024 - 04/2012
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	zotarolimusIBA 01/2022 - 04/2009
2	apixabanIBA 01/2022 - 10/2021
2	CreatinineIBA 01/2021 - 06/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 12/2011
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024
1	Indicators and Reagents (Reagents)IBA 03/2023
1	Spironolactone (Aldactone)FDA LinkGeneric 02/2023
1	Proteins (Proteins, Gene)FDA Link 02/2023
1	dapagliflozinIBA 02/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 02/2023
1	N 30IBA 01/2023
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2023
1	Angiotensin Receptor AntagonistsIBA 12/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2022
1	SugarsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 04/2019

Therapy/Procedure

88	Stents 03/2024 - 01/2009
43	Percutaneous Coronary Intervention 10/2023 - 11/2008
27	Drug-Eluting Stents 10/2023 - 01/2009
16	Therapeutics 01/2023 - 11/2008
6	Transcatheter Aortic Valve Replacement 01/2023 - 03/2013
4	Thrombectomy 01/2024 - 01/2016
4	Induced Hypothermia 09/2023 - 01/2016
4	Contraindications 01/2018 - 10/2013
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 06/2015
2	Cardiac Rehabilitation 01/2024 - 12/2022
2	Myocardial Revascularization 01/2018 - 07/2011
2	Catheters 12/2015 - 02/2015
1	Length of Stay 12/2022
1	Bioprosthesis 11/2019
1	Decompression 04/2019